Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortality

Issrah Jawad, Ivana Lukšić, Snorri Bjorn Rafnsson, Issrah Jawad, Ivana Lukšić, Snorri Bjorn Rafnsson

Abstract

Objective: Sepsis is a complex and hard-to-define condition with many different interactions with other disorders. Presently, there are no estimates of the burden of sepsis and septicaemia at the global level and it was not included in the initial Global Burden of Disease study. Non-maternal sepsis has only recently received attention as a substantial global public health problem. The aim of this study was to assess available data on the burden of non-maternal sepsis, severe sepsis and septic shock in the community and to identify key gaps in information needed to estimate the global burden of sepsis.

Methods: Literature review of English language-based studies reporting on the incidence, prevalence, mortality or case-fatality of sepsis, severe sepsis and septic shock. The available literature was searched using the MEDLINE database of citations and abstracts of biomedical research articles published between 1980 and 2008.

Findings: 8 studies reported incidence of sepsis, severe sepsis or septic shock at the national level (4 from the USA and 1 from Brazil, the UK, Norway and Australia). No studies on the incidence, prevalence, mortality or case-fatality from sepsis in developing countries were found. The population sepsis incidence ranged from 22 to 240/100 000 (most plausible estimates ranged from 149 to 240/100 000); of severe sepsis from 13 to 300/100 000 (most of the estimates were between 56 and 91/100 000); and of septic shock 11/100 000. Case-fatality rate depends on the setting and severity of disease. It can reach up to 30% for sepsis, 50% for severe sepsis and 80% for septic shock. While the data were compiled using strict inclusion and exclusion criteria, a degree of uncertainty still exists regarding the reported estimates.

Conclusion: The few national-level reports available allow only a very crude estimation of the incidence of sepsis in developed countries while there is apparent lack of data from developing countries. A clear and universal definition of sepsis as well as the development of a sound epidemiological framework to begin addressing the magnitude of this problem is urgently needed through research in developing countries.

Figures

Figure 1
Figure 1
Natural history of sepsis diagram. Key to the diagram: 1) Potentially modifiable risk factors that increase the probability of infection, SIRS and sepsis in a non-diseased population or severe sepsis and septic shock in septic patients; 2) Incidence of sepsis: the rate at which susceptible or exposed individuals become newly affected by sepsis; 3) Remission: the rate at which individuals with sepsis stop being a sepsis case; 4) Sepsis-complication: the rate at which patients experience a complication of sepsis or start to suffer from sequelae of sepsis; 5) Case-fatality (or population mortality rate or relative risk of dying): the rate at which patients die from sepsis; 6) Complication-fatality: the rate at which patients die as a result of a complication of sepsis; 7) Individuals with sequelae who are exposed to the risk factor(s) and are susceptible to acquire infection, SIRS, sepsis, severe sepsis or septic shock again; 8) General mortality: the rate at which the population dies from any condition other than sepsis. Infection has been defined as a pathological process caused by invasion of normally sterile tissue/fluid/body cavity by pathogenic microorganisms; Systemic inflammatory response (SIRS) is a systemic inflammatory state characterized by changes in body temperature, heart rate, respiratory rate and leukocyte blood count; Sepsis is defined as confirmed or suspected infection and SIRS; Severe sepsis is defined as sepsis complicated by organ dysfunction; Septic shock in adults is defined as state of acute circulatory failure characterized by persistent arterial hypotension unexplained by other causes. Paediatric septic shock is defined as tachycardia with signs of decreased perfusion including decreased peripheral pulses, altered alertness, and cool extremities or reduced urinary output. Hypotension occurs later than in adults and is a sign of late and decompensated shock in children [3,4].
Figure 2
Figure 2
Results from the literature review of the global burden (incidence, prevalence and mortality/case-fatality) of sepsis.

References

    1. Murray CJ, Lopez A. Evidence-based health policy – lessons from the Global Burden of Disease Study. Science. 1996;274:740–3. doi: 10.1126/science.274.5288.740.
    1. Murray CJ, Lopez A. Alternative projections of mortality and disability by cause1990–2020: Global Burden of Disease Study. Lancet. 1997;349:1498–504. doi: 10.1016/S0140-6736(96)07492-2.
    1. Levy M. Interview with M. Levy. Soc Crit Care Med 2001. [Online] Available at: [Accessed on March 2008]
    1. Brun-Buisson C. Epidemiology of severe sepsis. Presse Med. 2006;35:513–20. doi: 10.1016/S0755-4982(06)74627-9.
    1. Dolea C, Stein C. Global burden of maternal sepsis in the year 2000: evidence and information for policy (EIP). Geneva: World Health Organization, 2003.
    1. Moss M. Epidemiology of sepsis: race, sex, and chronic alcohol abuse. Clin Infect Dis. 2005;4(Suppl 7):S490–7. doi: 10.1086/432003.
    1. Lever A, Mackenzie I. Sepsis: definition, epidemiology and diagnosis. BMJ. 2007;335:879–83. doi: 10.1136/.
    1. Rangel-Frausto M, Wenzel R. The epidemiology and natural history of bacterial sepsis. In: Fein A, Abraham E, Balk R, Bernard G, Bone R, Dantzker D, Fink M. Sepsis and multi-organ failure. Williams & Wilkins: Baltimore, Maryland, 1997.
    1. Martin GS, Mannino D, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546–54. doi: 10.1056/NEJMoa022139.
    1. Angus DC, Linde-Zwirble W, Lidicker J, Carcillo G, Pinsky M. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303–10. doi: 10.1097/00003246-200107000-00002.
    1. Bou Monterde R, Alfonso-Diego R, Ferrando-Monleon J, Sanchez-Villanueva Bracho S, Aguilar Escriva L, Reig A. Incidencia estimada y análisis de la sepsis en un área de Valencia. An Pediatr (Barc) 2007;66:573–7. doi: 10.1157/13107391.
    1. Karlsson S, Varpula M, Ruokonen E, Pettilä V, Parviainen I, Ala-Kokko TI, et al. Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study. Intensive Care Med. 2007;33:435–43. doi: 10.1007/s00134-006-0504-z.
    1. Flaatten H. Epidemiology of sepsis in Norway in 1999. Crit Care. 2004;8:R180–4. doi: 10.1186/cc2867.
    1. Silva E, Pedro Mde A, Sogayar AC, Mohovic T, Silva CL, Janiszewski M, et al. Brazilian Sepsis Epidemiological Study (BASES study). Crit Care. 2004;8:R251–60. doi: 10.1186/cc2892.
    1. Elhag KM, Mustafa AK, Sethi SK. Septicaemia in a teaching hospital in Kuwait - I: Incidence and aetiology. J Infect. 1985;10:17–24. doi: 10.1016/S0163-4453(85)80004-9.
    1. Hoa NT, Diep TS, Wain J, Parry CM, Hien TT, Smith MD, et al. Community-acquired septicaemia in southern Viet Nam: the importance of multidrug-resistant Salmonella typhi. Trans R Soc Trop Med Hyg. 1998;92:503–8. doi: 10.1016/S0035-9203(98)90891-4.
    1. Harrison DA, Welch CA, Eddleston JM. The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database. Crit Care. 2006;10:R42. doi: 10.1186/cc4854.
    1. Braun L, Riedel A, Cooper LV. Severe sepsis in managed care: analysis of incidence, one-year mortality, and associated costs of care. J Manag Care Pharm. 2004;10:521–30.
    1. Finfer S, Bellomo R, Lipman J, French C, Dobb G, Myburgh J. Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med. 2004;30:589–96. doi: 10.1007/s00134-004-2157-0.
    1. Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, et al. Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med. 2007;33:606–18. doi: 10.1007/s00134-006-0517-7.
    1. Salvo I, de Cian W, Musicco M, Langer M, Piadena R, Wolfler A, et al. The Italian SEPSIS study: preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med. 1995;21(Suppl 2):S244–9. doi: 10.1007/BF01740762.
    1. Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med. 2003;167:695–701. doi: 10.1164/rccm.200207-682OC.
    1. Centres for Disease Control and Prevention. Monthly vital statistics report 1993: National Centre for Health Statistics – mortality patterns. Atlanta: CDC, 1990.
    1. Devine OJ, Louis TA, Halloran ME. Empirical Bayes methods for stabilizing incidence rates before mapping. Epidemiology. 1994;5:622–30. doi: 10.1097/00001648-199411000-00010.
    1. Eachempati SR, Hydo L, Barie PS. Gender-based differences in outcome in patients with sepsis. Arch Surg. 1999;134:1342–7. doi: 10.1001/archsurg.134.12.1342.
    1. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644–55. doi: 10.1378/chest.101.6.1644.
    1. Jaimes F. A literature review of the epidemiology of sepsis in Latin America. Rev Panam Salud Publica. 2005;18:163–71. doi: 10.1590/S1020-49892005000800003.
    1. Kober K, Van Damme W. Scaling up access to antiretroviral treatment in southern Africa: who will do the job? Lancet. 2004;364:103–7. doi: 10.1016/S0140-6736(04)16597-5.

Source: PubMed

3
Předplatit